位置：成果数据库 > 期刊 > 期刊详情页
mir-27是乳腺癌进展和生存的预后指标
  • ISSN号：1932-6203
  • 期刊名称：PLos One
  • 时间：2012.12.11
  • 页码：10-17
  • 相关项目：肿瘤相关巨噬细胞分泌的CCL18通过下调miR98的表达促进乳腺癌的转移
作者： 苏逢锡等|
同期刊论文项目
肿瘤相关巨噬细胞分泌的CCL18通过下调miR98的表达促进乳腺癌的转移
期刊论文 19
同项目期刊论文
HER-2 positive breast cancer is associated wi
Long noncoding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progressi
Which nomogram is bestfor predicting non-sentinel lymph node metastasis in breast cancer patients? A
miR-21 Induces Myofibroblast Differentiation and Promotes the Malignant Progression of Breast Phyllo
What lies behind chemotherapy-induced amenorrhea for breast cancer patients: a meta-analysis
Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A
Preoperative CA 15-3 levels predict the prognosis of nonmetastatic luminal A breast cancer
Effect of Implant vs. Tissue Reconstruction on Cancer Specific Survival Varies by Axillary Lymph Nod
Potentiated DNA damage response in circulating breast tumor cells confers resistance to chemotherapy
MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells
HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after i
MiR-27 as a prognostic marker for breast cancer progression and patient survival.
CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients?
保乳手术治疗三阴乳腺癌的安全性及其预后分析
乳腺癌术后放疗诱发性肉瘤的治疗进展
超声引导下经颈内静脉植入静脉输液泵1856例体会